Correlation Between OncoCyte Corp and Volitionrx
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Volitionrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Volitionrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Volitionrx, you can compare the effects of market volatilities on OncoCyte Corp and Volitionrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Volitionrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Volitionrx.
Diversification Opportunities for OncoCyte Corp and Volitionrx
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between OncoCyte and Volitionrx is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Volitionrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Volitionrx and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Volitionrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Volitionrx has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Volitionrx go up and down completely randomly.
Pair Corralation between OncoCyte Corp and Volitionrx
Considering the 90-day investment horizon OncoCyte Corp is expected to under-perform the Volitionrx. But the stock apears to be less risky and, when comparing its historical volatility, OncoCyte Corp is 2.09 times less risky than Volitionrx. The stock trades about -0.26 of its potential returns per unit of risk. The Volitionrx is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 76.00 in Volitionrx on September 14, 2024 and sell it today you would lose (15.00) from holding Volitionrx or give up 19.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
OncoCyte Corp vs. Volitionrx
Performance |
Timeline |
OncoCyte Corp |
Volitionrx |
OncoCyte Corp and Volitionrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with OncoCyte Corp and Volitionrx
The main advantage of trading using opposite OncoCyte Corp and Volitionrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Volitionrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Volitionrx will offset losses from the drop in Volitionrx's long position.OncoCyte Corp vs. Burning Rock Biotech | OncoCyte Corp vs. Neuronetics | OncoCyte Corp vs. DarioHealth Corp | OncoCyte Corp vs. Sera Prognostics |
Volitionrx vs. Electrocore LLC | Volitionrx vs. Evogene | Volitionrx vs. Evolus Inc | Volitionrx vs. OncoCyte Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |